Boulder Diagnostics Overview

  • Founded
  • 2009

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $7.9M

Boulder Diagnostics General Information


Developer of immunology-based assays designed to treat rheumatology and infectious diseases. The company is primarily engaged in developing diagnostic reagents and tests for infectious diseases and other protein targets.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 6395 Gunpark Drive
  • Suite W
  • Boulder, CO 80301
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boulder Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 31-Jul-2014 $7.9M 00.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view Boulder Diagnostics’s complete valuation and funding history, request access »

Boulder Diagnostics Executive Team (3)

Name Title Board Seat Contact Info
Roy Mondesire Ph.D Scientific Consultant
You’re viewing 1 of 3 executive team members. Get the full list »

Boulder Diagnostics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Reich Web Consulting Corporation Minority 000 0000 000000 0
Ventac Partners Venture Capital Minority 000 0000 000000 0
To view Boulder Diagnostics’s complete investors history, request access »